At a briefing from the UK medicines regulator on the investigation into the @AstraZeneca vaccine and whether it’s directly causing rare blood clots, Prof Van Tam says we have arrived at a “course correction” for the @AstraZeneca jab. Over 20m doses have been given in the UK.
No effective medicine is without risk, says Dr June Raine. And safety reviews have detected suspected blood clots in an extremely small number of people.

The evidence is firming up but more work is needed to establish beyond all doubt the vaccine has caused these side effects.
The benefits continue to outweigh the risks for the vast majority of people. There have been 79 case reports - all after the first dose - and 19 have died.

51 were women and 28 men, all aged 18 to 79 (3 under 30).

The risk of this type of rare clot is about 4 in a million.
Advice will be communicated on how to minimise risk, including symptoms the public should look out for.

She reiterates again this is “extremely rare” and the balance of benefits and known risks is still very favourable for the vast majority of people.
Full statement from the JCVI:

“JCVI currently advises that it is preferable for adults aged <30 years without underlying health conditions that put them at higher risk of severe COVID-19 disease, to be offered an alternative COVID-19 vaccine, if available”gov.uk/government/pub…
And an @MHRAgovuk statement.

The MHRA is *not* recommending age restrictions in COVID-19 Vaccine AstraZeneca vaccine use.

gov.uk/government/new…
Here’s the slides from the briefing, as presented by Prof Van-Tam.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Covid Fact Check UK

Covid Fact Check UK Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @fact_covid

6 Apr
More evidence has emerged on the relatively low risk of transmission outside compared with indoors.

@hpscireland data has shown that just one confirmed case of COVID-19 in every thousand is traced to outdoor transmission.

irishtimes.com/news/ireland/i…
“The relatively low numbers of cases resulting from outdoor transmission in the Republic is mirrored in international studies. A study of 1,245 cases in China found only three people were infected outdoors and they were in conversation without masks.”
“According to a review by the University of California of five global studies of transmission, the chances of getting Covid-19 in an indoor setting is 19 times greater than outdoors.”
Read 4 tweets
5 Apr
So as expected @BorisJohnson confirms Step Two of the roadmap will go ahead as planned on Monday 12 April. This is “fully justified by the data” and we are meeting the four government tests.

But “we cannot be complacent” and do not know “how strong the vaccine shield will be”.
“We see nothing in the present data that makes us think that we will have to deviate from the roadmap”, he says.
Chris Whitty says data from across the UK shows that there has been around a 60% reduction in symptomatic disease, and an 80% reduction in hospitalisation, from the first COVID-19 vaccine dose. He urges everyone to get their second dose.
Read 7 tweets
7 Feb
I’m seeing worrying comments from people that feel taking the Oxford/AZ jab is now pointless.

This is *absolutely* the wrong take: it remains a highly effective vaccine against severe illness for both the original virus AND the UK variant. Most likely the South African one too.
So take whatever vaccine you’re offered - the most important thing is to keep people out of hospitals.

If the vaccines do need to be updated (we don’t know yet), it will happen by autumn. Spring and summer will help keep transmission low until then.

There is no cause for alarm.
If you need further convincing please take a minute or so to watch this reassuring clip from the lead researcher on the vaccine, Professor Sarah Gilbert.
Read 4 tweets
7 Feb
Here’s the BBC’s take on the news about the South Africa variant: bbc.co.uk/news/uk-559677…

@AstraZeneca “expressed confidence that the vaccine would offer protection against serious cases, because it created neutralising antibodies similar to those of other coronavirus vaccines.”
Nevertheless the preliminary findings, first reported by the Financial Times and since confirmed by AstraZeneca, do suggest the vaccine offers only limited protection against mild and moderate disease caused by the variant.

The study is due to be published tomorrow.
The @UniofOxford told Reuters it was working with AstraZeneca to optimise the pipeline in vaccine production if it needed to adapt to a change in the virus.

It has said a new vaccine to work against mutated versions of the virus could be ready to deploy in the autumn, if needed.
Read 5 tweets
6 Feb
Today’s reported UK first vaccine dose figure falls fractionally short of the half million mark - but it’s still slightly up on the equivalent figure from one week earlier.

The total rises to almost 11.5 million first doses administered.
England and Wales are pretty neck to neck in terms of % of population to have received a first dose so far.
Read 4 tweets
5 Feb
Another strong day for reported first vaccine doses in the UK. Today’s number (480,560) is 64k up on the equivalent figure from one week ago.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!